MaricoQ4 FY24

Marico Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹900P/E: 58.0Market Cap: ₹1.2L CrSector: Agricultural Food & other Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Expect double-digit revenue growth in FY25 and beyond, driven by domestic core portfolios, foods, premium personal care, and international business.
  • Foods business aims to double scale by FY27, targeting a 25% CAGR.
  • Digital-first brands target doubling ARR in 3 years with 20%+ CAGR and achieving double-digit EBITDA margin.
  • International business expects sustained double-digit constant currency growth, with reduced dependence on Bangladesh market.
  • Project SETU aims to expand direct reach from 1 million to 1.5 million outlets by FY27, enhancing market share and distribution quality, supporting growth.
  • Rural demand expected to show significant improvement in the second half of the year, potentially growing faster than urban.
  • Volume growth in VAHO expected to improve with rationality in competitive intensity and better mix.
  • Overall, strive for low teen profit growth alongside healthy revenue growth.

See what Marico management said on margin guidance — free account, 30 seconds.

Fundraise plans

The document does not mention any current or future plans for fundraising through debt or equity. Key points relevant to investment and funding are: - Project SETU involves an outlay of INR 80-100 crores over 3 years focused on expanding direct distribution. - This investment will be funded internally via reallocation of resources and cost savings from optimizing wholesale channel spends, supply chain efficiencies, and use of technology. - The company aims for Project SETU to be cost-neutral without impacting profitability. - No mention of raising external capital through debt or equity in the near or medium term. - Focus is on internal funding and resource optimization for growth initiatives rather than external fundraising.

See what Marico management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Marico has committed investments of INR 80 to 100 crores by FY27 toward Project SETU, focused on coverage and infrastructure enhancement and demand generation initiatives.
  • Project SETU aims to expand direct reach from 1 million to 1.5 million outlets over 3 years (until FY27).
  • The investment will be funded by reallocating resources and optimizing spends in wholesale and organized trade channels, not as an incremental cost.
  • Project SETU also includes large-scale use of technology and analytics to improve process efficiencies and reduce wastages in the supply chain.
  • The rollout of Project SETU is a key strategic initiative to drive market share gains, weighted distribution, and premiumization in the domestic business.
  • Foods portfolio plans for acceleration in growth, including expansion into general trade and innovation, targeting consistent 20%+ CAGR over the medium term.

Track Marico — get its next earnings analysis in your feed

How does Marico rank vs peers in Agricultural Food & other Products?

Pro feature
ThisMarico
Rev 3Mar 3

How does Marico rank in Agricultural Food & other Products?

Compare Marico against every Agricultural Food & other Products company (Q4 FY24) on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

Others in Agricultural Food & other Products this season

  • Rana Sugars (Q2 FY27)

    . Key results statement takeaways from Rana Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Kohinoor Foods (Q2 FY27)

    EBITDA for the quarter ended September 30, 2026, is reported as ₹44 crore, a 13% year-on-year increase from ₹39 crore. Key results statement takeaways from Kohi

  • NFP Sampoorna (Q2 FY27)

    Revenue from Operations for the half-year ended September 30, 2026: ₹253,834.309 thousand (Standalone), ₹253,834.309 thousand (Consolidated). Key results statem

  • M K Proteins (Q2 FY27)

    Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs . Key results statement takeaways from M K Proteins Ltd's Q2 FY27 results stat

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →